11 Seotember 2015 - PHARMAC is pleased to announce the approval of an agreement with Natural Health Laboratories Limited (a subsidiary of Douglas Pharmaceuticals) to fund a renal multivitamin (Clinicians Renal Vit).

This was the subject of a consultation letter dated 7 August 2015, available on PHARMAC’s website.

The proposal was approved as consulted on. In summary, the effect of the decision is that:

• Clinicians Renal Vit will be listed in Section B and Part II of Section H of the Pharmaceutical Schedule from 1 October 2015. Funding is restricted to patients with chronic kidney disease (CKD) who are on dialysis or with CKD Grade 5.
• Pricing will be added to the existing listing in Part II of Section H for a multivitamin and mineral supplement, which is restricted to patients with burns and other criteria.

For more details, go to: http://www.pharmac.health.nz/news/notification-clinicians-renal/